XBIT: Rasio rega marang pendapatan XBiotech Inc
Patent-protected antibody development tools create a significant barrier to entry for competitors. This price-to-sales chart illustrates the asset's dynamics, where the parameter value reaches 597.60. XBiotech Inc. relies on True Human technology in oncology, investing billions into molecular biology. Business stability is guaranteed by its own manufacturing plant in the US, which ensures the full production cycle of bio-substances.
Rincian analitis perusahaan XBiotech Inc. (XBIT)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- statistik nilai buku emiten:
- statistik kawajiban utang lan likuiditas:
Utang Agregat marang Modal XBiotech Inc.|XBIT - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal xbiotech.com|XBIT - Gunggung utang perusahaan|Utang marang nilai buku XBiotech USA|XBIT - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan XBiotech|Rasio jangkoan perantara xbiotech.com
- data bathi resik lan rasio valuasi:
XBIT - Bathi resik|Prakiraan bathi perusahaan XBiotech Inc.|XBIT - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep xbiotech.com|XBIT - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan XBiotech USA|XBIT - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan XBiotech|XBIT - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan xbiotech.com|XBIT - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep XBiotech Inc.
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:XBIT (XBiotech Inc)
Investors often waver between searching for undervalued assets and fearing the purchase of a declining business. This ratio compares the market value of XBiotech Inc. (XBIT) to its operating income, reflecting the cost of each unit of revenue. By analyzing the price-to-sales trend, one can identify hidden opportunities or overvaluation risks. For XBiotech Inc. (XBIT), this indicator depends directly on the efficiency of antibody licensing and the volume of royalties received.
Perusahaan pesaing
beigene.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S HALO (Halozyme)|Revolution Medicines Inc - Rasio rega marang pendapatan|Ascentage - Multiplikator P/S|Koefisien rega marang pendapatan CG Oncology Therapeutics CGON|UroGen Pharma Ltd. (URGN) - Rasio rega marang pendapatan|Rega marang dodolan bicara.com (BCAX)|Kapitalisasi marang pendapatan PSNL|ERAS (Erasca Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S DCTH|YMAB - Rega marang dodolan|Multiplikator P/S AURA (Aura Biosciences, Inc.)|CADL - Kapitalisasi marang pendapatan|Accuray - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics, Inc) - Kapitalisasi marang pendapatan|Citius Oncology Inc - Rasio kapitalisasi pasar marang pendapatan|HURA (TuHURA Biosciences Inc.) - Multiplikator P/S|protaratx.com (TARA) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Fate Therapeutics (FATE)|aadibio.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S TCRX (TScan Therapeutics, Inc.)|CSBR - Kapitalisasi marang pendapatan|CVM: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan ostherapies.com OSTX|RADX (Radiopharm Theranostics) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan ARTV|ANL (Adlai Nortye Ltd) - Multiplikator P/S|Rasio rega marang pendapatan VERU|Multiplikator P/S TPST|Koefisien rega marang pendapatan xiliotx.com|Renovaro - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan MURA (Mural Oncology PLC)|Kairos Pharma Inc - Multiplikator P/S|OnKure Therapeutics Inc (OKUR) - Kapitalisasi marang pendapatan|GDTC: Multiplikator P/S|Curis (CRIS) - Multiplikator P/S|Rasio rega marang pendapatan Apollomics Inc.|Rasio kapitalisasi marang pendapatan THAR (Tharimmune Inc)|Multiplikator P/S ADVB|Kapitalisasi marang pendapatan Genprex Inc GNPX|Multiplikator P/S CLDI (Calidi Biotherapeutics, Inc.)|sunshinebiopharma.com (SBFM) - Rega marang dodolan|XBIO - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan SLRX (Salarius Pharmaceuticals Inc)|PPBT (Purple Biotech Corp) - Kapitalisasi marang pendapatan|American Oncology Network, Inc. - Rasio kapitalisasi pasar marang pendapatan|BGNE (BeiGene, Ltd.) - Multiplikator P/S|Kapitalisasi marang pendapatan checkpointtx.com (CKPT)|Kapitalisasi marang pendapatan ELEV (Elevation Oncology)|Multiplikator P/S icadmed.com (ICAD)|Rasio rega marang pendapatan Ikena Oncology IKNA|Rasio kapitalisasi pasar marang pendapatan NTBL|Viracta - Multiplikator P/S|Rega marang dodolan morphosys.com|NAYA (NAYA Biosciences Inc.) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan AAPGV
